-
-
-
-
-
-
-
Rigel Pharmaceuticals (RIGL) Tops Q4 EPS by 1354c
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Rigel Pharmaceuticals (RIGL)
-
-
-
-
-
-
-
Rigel Pharmaceuticals (RIGL) PT Raised to $55 at Citi
-
-
-
-
-
-
-
Rigel Pharma (RIGL) Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition
-
-
-
-
-
-
-
Rigel Pharma (RIGL) Expands Relationship with Kissei to include REZLIDHIA in Japan, Korea and Taiwan
-
-
-
-
-
416,808 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

